Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001903596-24-000456
Filing Date
2024-08-01
Accepted
2024-08-01 16:05:41
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 kays_10ka.htm   iXBRL 10-K/A 43173
2 ex31_1.htm EX-31.1 15445
3 ex32_1.htm EX-32.1 7735
4 GRAPHIC image_001.jpg GRAPHIC 4685
  Complete submission text file 0001903596-24-000456.txt   277764

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE kays-20240801.xsd EX-101.SCH 3027
6 XBRL LABEL FILE kays-20240801_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE kays-20240801_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT kays_10ka_htm.xml XML 5767
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

EIN.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-177532 | Film No.: 241166555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)